Cargando…

Preoperative Imaging with [(18)F]-Fluorocholine PET/CT in Primary Hyperparathyroidism

Primary hyperparathyroidism (pHPT) is a common endocrine disorder due to hyperfunctioning parathyroid glands. To date, the only curing therapy is surgical removal of the dysfunctional gland, making correct detection and localization crucial in order to perform a minimally invasive parathyroidectomy....

Descripción completa

Detalles Bibliográficos
Autores principales:	Dekorsy, Franziska J., Beyer, Leonie, Spitzweg, Christine, Schmidmaier, Ralf, Todica, Andrei, Trupka, Arnold, Cyran, Clemens C., Berger, Frank, Ladurner, Roland, Zimmermann, Petra, Knösel, Thomas, Bartenstein, Peter, Lottspeich, Christian, Wenter, Vera
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9143217/ https://www.ncbi.nlm.nih.gov/pubmed/35629070 http://dx.doi.org/10.3390/jcm11102944

Ejemplares similares

Primary presentation and clinical course of pediatric and adolescent patients with differentiated thyroid carcinoma after radioiodine therapy
por: Burgard, Caroline, et al.
Publicado: (2023)

Effects of the Minimal Extrathyroidal Extension on Early Response Rates after (Adjuvant) Initial Radioactive Iodine Therapy in PTC Patients
por: Ahmaddy, Freba, et al.
Publicado: (2020)

Clinical impact of follicular oncocytic (Hürthle cell) carcinoma in comparison with corresponding classical follicular thyroid carcinoma
por: Wenter, Vera, et al.
Publicado: (2020)

(18)F-FDG-PET/CT in Patients with Advanced, Radioiodine Refractory Thyroid Cancer Treated with Lenvatinib
por: Ahmaddy, Freba, et al.
Publicado: (2021)

Course of Disease and Clinical Management of Patients with Poorly Differentiated Thyroid Carcinoma
por: Grawe, Freba, et al.
Publicado: (2021)

Comparison of somatostatin receptor expression in patients with neuroendocrine tumours with and without somatostatin analogue treatment imaged with [(18)F]SiTATE
por: Eschbach, Ralf S., et al.
Publicado: (2023)

The diagnostic challenge of coexistent sarcoidosis and thyroid cancer – a retrospective study
por: Wenter, Vera, et al.
Publicado: (2021)

Dosimetry and optimal scan time of [(18)F]SiTATE-PET/CT in patients with neuroendocrine tumours
por: Beyer, Leonie, et al.
Publicado: (2021)

(18)F-Fluorocholine PET and Multiphase CT Integrated in Dual Modality PET/4D-CT for Preoperative Evaluation of Primary Hyperparathyroidism
por: Pretet, Valentin, et al.
Publicado: (2020)

(18)F-Fluorocholine PET and 4D-CT in Patients with Persistent and Recurrent Primary Hyperparathyroidism
por: Latge, Adrien, et al.
Publicado: (2021)

Feasibility of [(68)Ga]Ga-FAPI-46 PET/CT for detection of nodal and hematogenous spread in high-grade urothelial carcinoma
por: Unterrainer, Lena M., et al.
Publicado: (2022)

Salvage PRRT with (177)Lu-DOTA-octreotate in extensively pretreated patients with metastatic neuroendocrine tumor (NET): dosimetry, toxicity, efficacy, and survival
por: Rudisile, S., et al.
Publicado: (2019)

Diagnostic performance of PET/CT in the detection of liver metastases in well-differentiated NETs
por: Grawe, Freba, et al.
Publicado: (2023)

(68)Ga-EMP-100 PET/CT—a novel ligand for visualizing c-MET expression in metastatic renal cell carcinoma—first in-human biodistribution and imaging results
por: Mittlmeier, Lena M., et al.
Publicado: (2021)

Correlation of an Index-Lesion-Based SPECT Dosimetry Method with Mean Tumor Dose and Clinical Outcome after (177)Lu-PSMA-617 Radioligand Therapy
por: Völter, Friederike, et al.
Publicado: (2021)

Incremental role of (18)F-fluorocholine PET/CT over technetium-99m-labeled MIBI scan in hyperparathyroidism
por: Behera, Abhishek, et al.
Publicado: (2016)

The Significance of 18F-Fluorocholine-PET/CT as Localizing Imaging Technique in Patients with Primary Hyperparathyroidism and Negative Conventional Imaging
por: Fischli, Stefan, et al.
Publicado: (2018)

Fluorine-18 Fluorocholine Positron Emission Tomography/Computed Tomography in Primary Hyperparathyroidism: A Case Report and Review of Literature
por: Ramalho, Diogo, et al.
Publicado: (2022)

Does (18)F-Fluorocholine PET/CT add value to positive parathyroid scintigraphy in the presurgical assessment of primary hyperparathyroidism?
por: Imperiale, Alessio, et al.
Publicado: (2023)

The added diagnostic value of complementary gadoxetic acid-enhanced MRI to (18)F-DOPA-PET/CT for liver staging in medullary thyroid carcinoma
por: Puhr-Westerheide, Daniel, et al.
Publicado: (2019)

Initial Evaluation of Therapy Response after Adjuvant Radioiodine Therapy in Patients with Early-Stage Papillary Thyroid Cancer—Does Time Matter?
por: Grawe, Freba, et al.
Publicado: (2022)

Total Tumor Volume on (18)F-PSMA-1007 PET as Additional Imaging Biomarker in mCRPC Patients Undergoing PSMA-Targeted Alpha Therapy with (225)Ac-PSMA-I&T
por: Unterrainer, Lena M., et al.
Publicado: (2022)

(68)Ga-EMP-100 PET/CT—a novel method for non-invasive assessment of c-MET expression in non-small cell lung cancer
por: Unterrainer, Lena M., et al.
Publicado: (2022)

Fluorocholine PET Imaging of Parathyroid Disease
por: Prabhu, Meghana, et al.
Publicado: (2018)

Feasibility of Different Tumor Delineation Approaches for (18)F-PSMA-1007 PET/CT Imaging in Prostate Cancer Patients
por: Mittlmeier, Lena M., et al.
Publicado: (2021)

Parathyroid imaging with (18)F-fluorocholine PET/CT as a first-line imaging modality in primary hyperparathyroidism: a retrospective cohort study
por: Broos, Wouter A. M., et al.
Publicado: (2019)

High turnover renal osteodystrophy due to secondary hyperparathyroidism diagnosed by (18)F-Fluorocholine combined with (18)F-NaF PET/CT
por: Xiong, Lin, et al.
Publicado: (2021)

Assessment of right ventricular sympathetic dysfunction in patients with arrhythmogenic right ventricular cardiomyopathy: An (123)I-metaiodobenzylguanidine SPECT/CT study
por: Todica, Andrei, et al.
Publicado: (2018)

Identification and characterization of myocardial metastases in neuroendocrine tumor patients using 68Ga-DOTATATE PET-CT
por: Kunz, Wolfgang G., et al.
Publicado: (2018)

(18)F-Fluorocholine PET/CT, Tc-99m-MIBI and TC-99m-MDP SPECT/CT in Tertiary Hyperparathyroidism with Renal Osteodystrophy
por: Ferrari, Cristina, et al.
Publicado: (2020)

Comparison of [(18)F]fluorocholine PET/CT with [(99)mTc]sestamibi and ultrasonography to detect parathyroid lesions in primary hyperparathyroidism: a prospective study
por: Manyalich-Blasi, Marti, et al.
Publicado: (2022)

Validation of the SSTR-RADS 1.0 for the structured interpretation of SSTR-PET/CT and treatment planning in neuroendocrine tumor (NET) patients
por: Grawe, Freba, et al.
Publicado: (2023)

Preoperative Localization Studies in Primary Hyperparathyroidism
por: Uludag, Mehmet
Publicado: (2017)

Troubleshooting for F-18 Fluorocholine Synthesis: An Institutional Experience
por: Vatsa, Rakhee, et al.
Publicado: (2018)

[(18)F]FDG PET accurately differentiates infected and non-infected non-unions after fracture fixation
por: Wenter, Vera, et al.
Publicado: (2016)

Role of (18)Fluorocholine Positron Emission Tomography/Computed Tomography in the Localization of Culprit Lesions in Patients of Persistent/Recurrent Primary Hyperparathyroidism: A Prospective Study in COVID Times
por: Wakankar, Ritwik, et al.
Publicado: (2023)

Simulated ward round training in the medical curriculum Munich
por: Lottspeich, Christian, et al.
Publicado: (2021)

Update on Preoperative Parathyroid Localization in Primary Hyperparathyroidism
por: Park, Hye-Sun, et al.
Publicado: (2022)

(18)F-Fluorocholine-Positron Emission Tomography/Computerised Tomography is Useful in Localising (99m)Tc-Sesta-methoxyisobutylisonitrile-Negative Parathyroid Cyst Causing Normocalcemic Primary Hyperparathyroidism
por: Dutta, Deep, et al.
Publicado: (2018)

(18)F-Fluorocholine PET/CT Compared with Current Imaging Procedures for Preoperative Localization of Hyperfunctioning Parathyroids in Patients with Chronic Kidney Disease
por: Aymard, Samuel, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_9225gpjhmbdr5lg48vkmqqb64m